|
|
|
Article Cited by others RESEARCH ARTICLE
Comparative cardiovascular safety of risperidone and olanzapine, based on electrocardiographic parameters and blood pressure: A prospective open label observational study
Choure Balwant Kisanrao, Gosavi Devesh, Nanotkar Sanjay
Year : 2014| Volume: 46| Issue : 5 | Page no: 493-497 | This article has been cited by | | 1 |
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort |
|
| | Georgios Schoretsanitis, Céline Dubath, Claire Grosu, Marianna Piras, Nermine Laaboub, Setareh Ranjbar, Nicolas Ansermot, Séverine Crettol, Frederik Vandenberghe, Franziska Gamma, Armin Gunten, Kerstin Jessica Plessen, Erich Seifritz, Philippe Conus, Chin B. Eap | | | Basic & Clinical Pharmacology & Toxicology. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects |
|
| | Carla Rognoni, Arianna Bertolani, Claudio Jommi | | | Clinical Drug Investigation. 2021; 41(4): 303 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study |
|
| | Mikel Tous-Espelosin, Sonia Ruiz de Azua, Nagore Iriarte-Yoller, Aitor MartínezAguirre-Betolaza, Pedro M. Sanchez, Pablo Corres, Iñaki Arratibel-Imaz, Agurne Sampedro, Javier Peña, Sara Maldonado-Martín | | | Psychiatry Research. 2021; 295: 113580 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells |
|
| | Chien-Chih Chen, Li-Wen Hsu, Kuang-Tzu Huang, Shigeru Goto, Chao-Long Chen, Toshiaki Nakano | | | Scientific Reports. 2017; 7(1) | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
